Carole Ho

CIK 1724605 · Chief Medical Officer · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.97M

Companies

4

Total Filings

78

Lifetime Open-Market Net

-$13.21M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RPRX Director 13,103 $54.87 $719.0K $0 2 2026-06-08
DNLI Chief Medical Officer 242,391 $21.66 $5.25M -$13.21M 66 2025-08-14
BEAM Director $29.03 $0 5 2025-06-06
NGM BIOPHARMACEUTICALS INC (NGM) Delisted Director $1.54 $0 5 2024-04-08

Recent Filings · Page 6 of 8

78 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-10-13 DNLI Mixed -$1.88M EDGAR
2020-09-14 DNLI Sell (S) −3,689 -$114.4K EDGAR
2020-08-24 DNLI Mixed +3,689 -$64.2K EDGAR
2020-08-20 DNLI Grant (A) $0 EDGAR
2020-06-09 NGM BIOPHARMACEUTICALS INC (NGM) Delisted Grant (A) $0 EDGAR
2020-04-01 DNLI Exer (M) +4,250 $0 EDGAR
2020-04-01 DNLI Sell (S) −1,428 -$27.8K EDGAR
2020-02-12 DNLI Grant (A) $0 EDGAR
2019-12-23 DNLI Sell (S) −6,890 -$137.8K EDGAR
2019-08-22 DNLI Mixed +2,809 -$52.7K EDGAR
Showing 5160 of 78
Page 6 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.